Perrigo Ordinary Shares reported $4.07B in Loan Capital for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Bayer BAYN:GR EUR 33.79B 5.67B
Catalent CTLT:US USD 4.22B 123M
Coherus Biosciences CHRS:US USD 472.48M 1.98M
Endo International Ordinary Shares ENDP:US USD 1.42M 8.05B
Horizon Pharma HZNP:US USD 2.55B 2.3M
Nestle NESN:VX 43.42B 4.93B
Pacira Pharmaceuticals PCRX:US USD 655.82M 58.18M
Perrigo Ordinary Shares PRGO:US USD 4.07B 7.1M
Phibro Animal Health PAHC:US USD 460.81M 9.07M
Prestige Brands PBH:US USD 1.43B 14.95M
Reckitt Benckiser Group PLC RB/:LN GBP 7.16B 367M
Teva Pharmaceutical TEVA:IT USD 19.1B 606M
Xeris Pharmaceuticals Inc XERS:US USD 187.08M 48.57M
Zoetis ZTS:US USD 6.55B 1.34B